Maravai Lifesciences Holdings (MRVI) Net Margin Growth (3y) (2023 - 2026)
Maravai Lifesciences Holdings (MRVI) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | -798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -798.00 |
| Dec 31, 2025 | -16,908.00 |
| Sep 30, 2025 | -16,033.00 |
| Jun 30, 2025 | -21,191.00 |
| Mar 31, 2025 | -17,293.00 |
| Dec 31, 2024 | -13,709.00 |
| Sep 30, 2024 | -31,438.00 |
| Jun 30, 2024 | -8,829.00 |
| Mar 31, 2024 | -8,626.00 |
| Dec 31, 2023 | -16,306.00 |
| Sep 30, 2023 | -6,700.00 |
| Jun 30, 2023 | -2,040.00 |
| Mar 31, 2023 | -4,854.00 |